BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6177706)

  • 1. Changes in phenotypic expression in embryonic and adult cells treated with 5-azacytidine.
    Taylor SM; Jones PA
    J Cell Physiol; 1982 May; 111(2):187-94. PubMed ID: 6177706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.
    Taylor SM; Jones PA
    Cell; 1979 Aug; 17(4):771-9. PubMed ID: 90553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological characterization of a prolonged antileukemic effect of 5-azacytidine.
    Presant CA; Valeriote F; Vietti TJ
    Cancer Res; 1977 Feb; 37(2):376-81. PubMed ID: 64294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Azacytidine-induced uncoupling of differentiation and tumorigenicity in a murine cell line.
    Walker C; Ranney DF; Shay JW
    J Natl Cancer Inst; 1984 Oct; 73(4):877-85. PubMed ID: 6207331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of transformation progression in type 5 adenovirus-transformed rat embryo cells by a cloned protein kinase C beta 1 gene and reversal of progression by 5-azacytidine.
    Su ZZ; Shen R; O'Brian CA; Fisher PB
    Oncogene; 1994 Apr; 9(4):1123-32. PubMed ID: 7510863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine.
    Wakitani S; Saito T; Caplan AI
    Muscle Nerve; 1995 Dec; 18(12):1417-26. PubMed ID: 7477065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 5-azacytidine treatment on mouse embryonal carcinoma cells.
    Cremisi C
    J Cell Physiol; 1983 Aug; 116(2):181-90. PubMed ID: 6190823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Aza-2'-deoxycytidine: cell differentiation and DNA methylation.
    Taylor SM
    Leukemia; 1993 May; 7 Suppl 1():3-8. PubMed ID: 7683353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular differentiation, cytidine analogs and DNA methylation.
    Jones PA; Taylor SM
    Cell; 1980 May; 20(1):85-93. PubMed ID: 6156004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA modification, differentiation, and transformation.
    Jones PA; Taylor SM; Wilson V
    J Exp Zool; 1983 Nov; 228(2):287-95. PubMed ID: 6198436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M
    Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARgamma1 synthesis and adipogenesis in C3H10T1/2 cells depends on S-phase progression, but does not require mitotic clonal expansion.
    Cho YC; Jefcoate CR
    J Cell Biochem; 2004 Feb; 91(2):336-53. PubMed ID: 14743393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin.
    van Dijk A; Niessen HW; Zandieh Doulabi B; Visser FC; van Milligen FJ
    Cell Tissue Res; 2008 Dec; 334(3):457-67. PubMed ID: 18989703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SV40 T antigen inhibits expression of MyoD and myogenin, up-regulates Myf-5, but does not affect early expression of desmin or alpha 7 integrin during muscle development.
    Haider SR; Wang W; Kaufman SJ
    Exp Cell Res; 1994 Feb; 210(2):278-86. PubMed ID: 7507852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of myogenic determination on tumorigenicity of chemically transformed 10T1/2 cells.
    Hustad CM; Jones PA
    Mol Carcinog; 1991; 4(2):153-61. PubMed ID: 1710465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination.
    Konieczny SF; Emerson CP
    Cell; 1984 Oct; 38(3):791-800. PubMed ID: 6207933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of myogenic cell lines derived by 5-azacytidine treatment.
    Liu L; Harrington M; Jones PA
    Dev Biol; 1986 Oct; 117(2):331-6. PubMed ID: 2428680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT.
    Kitagawa Y; Kyo S; Takakura M; Kanaya T; Koshida K; Namiki M; Inoue M
    Clin Cancer Res; 2000 Jul; 6(7):2868-75. PubMed ID: 10914736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-azacytidine alters TGF-beta and BMP signaling and induces maturation in articular chondrocytes.
    Zuscik MJ; Baden JF; Wu Q; Sheu TJ; Schwarz EM; Drissi H; O'Keefe RJ; Puzas JE; Rosier RN
    J Cell Biochem; 2004 May; 92(2):316-31. PubMed ID: 15108358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cycle-dependent removal of certain methylated bases from DNA of 10T1/2 cells treated with N-methyl-N'-nitro-N-nitrosoguanidine.
    Smith GJ; Grisham JW; Kaufman DG
    Cancer Res; 1981 Apr; 41(4):1373-8. PubMed ID: 7214324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.